De gepoolde resultaten bevestigden gemiddeld 14,33% gewichtsverlies over de volledige studiegroep (inclusief lagere doseringen), met ook significante verbeteringen in BMI, tailleomtrek en nuchtere bloedsuikerwaarden
Most Cleveland Semaglutide patients experience gradual and steady weight loss over time
Qin J, Liu J, Wei Z, Li X, Chen Z, Li J, et al
Why do most people stop taking them within months of starting
Yet, the FDA cautions that the safety and effectiveness of combining a GLP-1 drug with additional ingredients, such as cyanocobalamin (Vitamin B-12) and pyridoxine (Vitamin B-6), have not been established